BamSEC and AlphaSense Join Forces
Learn More

CytomX Therapeutics Inc.

NASDAQ: CTMX    
Share price (1/8/25): $0.98    
Market cap (1/8/25): $76.9 million

Credit Agreements Filter

EX-10.23
from S-1 4 pages Amendment No. 1 to Master Loan and Security Agreement No. Cytox
12/34/56
EX-10.22
from S-1 27 pages Atel Ventures, Inc. Master Loan and Security Agreement No. Cytox Dated as of May 31, 2012
12/34/56
EX-10.21
from S-1 48 pages Master Loan and Security Agreement No. Cytoy Dated as of December 20, 2013
12/34/56
EX-4.4
from S-1 11 pages This Warrant Certifies That, for the Agreed Upon Value of $1.00 and for Other Good and Valuable Consideration, Including the Execution and Delivery of That Certain Master Loan and Security Agreement No. Cytox, Dated as of May 31, 2012, as Amended by Amendment No. 1 Dated as of January 31, 2013, (The “Loan”), This Warrant Is Issued to Atel Ventures, Inc., in Its Capacity as Trustee for Its Assignee Affiliated Funds Identified in That Certain Amendment and Restatement of Inter-Company Trust Agreement for Warrants Dated as of January 1, 2007, as Amended by Amendment No. 1 Dated as of March 15, 2010, and as May Be Further Amended and Restated From Time to Time, and Deemed Effective as of July 20, 2004 (“Holder”), by CytomX Therapeutics, Inc., a Delaware Corporation (The “Company”). 1. Issuance
12/34/56
EX-4.3
from S-1 11 pages This Warrant Certifies That, for the Agreed Upon Value of $1.00 and for Other Good and Valuable Consideration, Including the Execution and Delivery of That Certain Master Loan and Security Agreement No. Cytox, Dated as of May 31, 2012, (The “Loan”), This Warrant Is Issued to Atel Ventures, Inc., in Its Capacity as Trustee for Its Assignee Affiliated Funds Identified in That Certain Amendment and Restatement of Inter-Company Trust Agreement for Warrants Dated as of January 1, 2007, as Amended by Amendment No. 1 Dated as of March 15, 2010, and as May Be Further Amended and Restated From Time to Time, and Deemed Effective as of July 20, 2004 (“Holder”), by CytomX Therapeutics, Inc., a Delaware Corporation (The “Company”). 1. Issuance
12/34/56
EX-10
from DRS 4 pages Amendment No. 1 to Master Loan and Security Agreement No. Cytox
12/34/56
EX-10
from DRS 27 pages Atel Ventures, Inc. Master Loan and Security Agreement No. Cytox Dated as of May 31, 2012
12/34/56
EX-10
from DRS 48 pages Master Loan and Security Agreement No. Cytoy Dated as of December 20, 2013
12/34/56
EX-4
from DRS 11 pages This Warrant Certifies That, for the Agreed Upon Value of $1.00 and for Other Good and Valuable Consideration, Including the Execution and Delivery of That Certain Master Loan and Security Agreement No. Cytox, Dated as of May 31, 2012, as Amended by Amendment No. 1 Dated as of January 31, 2013, (The “Loan”), This Warrant Is Issued to Atel Ventures, Inc., in Its Capacity as Trustee for Its Assignee Affiliated Funds Identified in That Certain Amendment and Restatement of Inter-Company Trust Agreement for Warrants Dated as of January 1, 2007, as Amended by Amendment No. 1 Dated as of March 15, 2010, and as May Be Further Amended and Restated From Time to Time, and Deemed Effective as of July 20, 2004 (“Holder”), by CytomX Therapeutics, Inc., a Delaware Corporation (The “Company”). 1. Issuance
12/34/56
EX-4
from DRS 11 pages This Warrant Certifies That, for the Agreed Upon Value of $1.00 and for Other Good and Valuable Consideration, Including the Execution and Delivery of That Certain Master Loan and Security Agreement No. Cytox, Dated as of May 31, 2012, (The “Loan”), This Warrant Is Issued to Atel Ventures, Inc., in Its Capacity as Trustee for Its Assignee Affiliated Funds Identified in That Certain Amendment and Restatement of Inter-Company Trust Agreement for Warrants Dated as of January 1, 2007, as Amended by Amendment No. 1 Dated as of March 15, 2010, and as May Be Further Amended and Restated From Time to Time, and Deemed Effective as of July 20, 2004 (“Holder”), by CytomX Therapeutics, Inc., a Delaware Corporation (The “Company”). 1. Issuance
12/34/56